Effectiveness of pneumococcal conjugate vaccine in infants by maternal influenza vaccination status

Katharina L van Santen1, Robert A Bednarczyk, Dzifa Adjaye-Gbewonyo

  • 1From the *Center for Health Research-Southeast, Kaiser Permanente; †Rollins School of Public Health; and ‡Emory Vaccine Center, Emory University, Atlanta GA.

Insights

Maternal influenza vaccination combined with infant pneumococcal conjugate vaccine (PCV) offers superior protection against acute otitis media and respiratory infections in infants compared to PCV alone.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health

Background:

  • Influenza virus infection increases susceptibility to secondary pneumococcal infections, particularly in infants.
  • Infants under six months are most vulnerable and cannot receive influenza vaccines directly.
  • Maternal influenza vaccination can provide passive immunity to young infants.

Purpose of the Study:

  • To evaluate the effectiveness of combined maternal influenza vaccination and infant pneumococcal conjugate vaccine (PCV) against common infant infections.
  • To compare the protective benefits of this combined strategy versus PCV alone.

Main Methods:

  • Retrospective cohort study of 9807 mother-infant pairs.
  • Assessed outcomes including acute otitis media and medically attended acute respiratory infection in the first year of life.
  • Calculated vaccine effectiveness using incidence rate ratios during periods of influenza circulation.

Main Results:

  • Combined maternal influenza vaccine and PCV showed 39.6% effectiveness against acute respiratory infections and 47.9% against acute otitis media.
  • PCV alone demonstrated lower effectiveness: 29.8% for respiratory infections and 37.6% for otitis media.

Conclusions:

  • The combination of maternal influenza vaccination and infant PCV provides enhanced protection against otitis media and acute respiratory infections.
  • This dual vaccination strategy is more effective than PCV alone in protecting infants during their first year of life.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...